propidium has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Q; Li, Z; Pan, D; Wang, H; Wang, Y; Wu, G; Yao, J; Zhao, L; Zhu, L | 1 |
1 other study(ies) available for propidium and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
Article | Year |
---|---|
Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Division; Cell Line, Tumor; Checkpoint Kinase 2; Coloring Agents; Drug Resistance, Multiple; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Female; Flavonoids; Fluorescent Dyes; G2 Phase; Genes, p53; Humans; NF-kappa B; Propidium; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Rhodamine 123; Tetrazolium Salts; Thiazoles | 2013 |